Spectral AI Receives UKCA Mark and FDA Class 1 Medical Device Classification for DeepView SnapShot Wound Imaging System

October 19, 2023

DENVER, Colo., Oct 19, 2023 (247marketnews.com)- Spectral AI, Inc. (NASDAQ:MDAI) stated, this morning, that its DeepView SnapShot® Wound Imaging System was UK Conformity Assessed (UKCA)-marked for use in the United Kingdom and has received Class 1 medical device classification with the United States Food and Drug Administration (FDA).

Spectral AI is trading at $2.95, up $0.36 (+13.90%), on 315.2K premarket shares traded.

Its 52-week range is $2.20 to $19.50. $4 is its key inflection point, after that there’s a little resistance in the mid-$4 range and a lot of room to run much high, if it picks up massive volume.

 24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to 247marketnews.com or https://247marketnews.com/terms-disclaimer/ for further information.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.